LIPOCINE INC. Quantifying Misstatement in Current Year Financial Statements, Amount
LIPOCINE INC. (LPCN) reported Quantifying Misstatement in Current Year Financial Statements, Amount of $271.00 thousand for the 9-month period ending 2014-09-30, per its 10-Q filed 2015-11-12.
Discontinued › Notes
us-gaap:QuantifyingMisstatementInCurrentYearFinancialStatementsAmount · last filed 2015-11-12
- LIPOCINE INC. quantifying misstatement in current year financial statements, amount for the quarter ending 2014-09-30 was $0.00.
| Period end | Quantifying Misstatement in Current Year Financial Statements, Amount 3 month | Quantifying Misstatement in Current Year Financial Statements, Amount 6 month | Quantifying Misstatement in Current Year Financial Statements, Amount 9 month |
|---|---|---|---|
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $271.00K 10-Q · filed 2015-11-12 | |
| 2014-06-30 | $271.00K 10-Q · filed 2015-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |